Connection
Jill Johnson to Drug Utilization
This is a "connection" page, showing publications Jill Johnson has written about Drug Utilization.
|
|
Connection Strength |
|
|
|
|
|
0.163 |
|
|
|
-
King J, McAdam-Marx C, McCaleb R, Davis D, Bemberg GB, Johnson JT. Cost and Utilization Outcomes After Exclusion of Dipeptidyl Peptidase-4 Inhibitors and Other Diabetes Drug Category Changes in a Self-Funded, State Employee Managed Care Plan. J Manag Care Spec Pharm. 2019 Jun; 25(6):646-651.
Score: 0.163